Spots Global Cancer Trial Database for immunization
Every month we try and update this database with for immunization cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer | NCT00078494 | Nasopharyngeal ... | EBV-LMP-2 | - | National Institutes of Health Clinical Center (CC) | |
| Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype | NCT00001572 | B Cell Lymphoma Follicular Lymp... Neoplasm | Id-KLH Vaccine QS-21 (Stimulat... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| PCOM2 - The Physician Communication Intervention, Version 2.0 | NCT05336240 | HPV Infection Preventive Heal... | Physician Commu... Physician Commu... | 9 Years - 17 Years | University of Colorado, Denver | |
| Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer | NCT00078494 | Nasopharyngeal ... | EBV-LMP-2 | - | National Institutes of Health Clinical Center (CC) | |
| Trial to Reduce Alloimmunization to Platelets (TRAP) | NCT00000589 | Blood Platelets Hematologic Dis... Immunization Leukemia, Myelo... Blood Transfusi... | platelet transf... | 15 Years - 75 Years | National Heart, Lung, and Blood Institute (NHLBI) | |
| Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA | NCT02211027 | Head and Neck S... | Semi-allogenic ... | 18 Years - | University of Pittsburgh | |
| Immunization of Patients With Non Small Cell Lung Cancer (NSCLC) | NCT00793208 | Non Small Cell ... | semi-allogeneic... | 18 Years - | University of Pittsburgh | |
| Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) | NCT05672927 | Immunization HPV Infection Human Papilloma... | 9-valent HPV va... 9-valent HPV va... | 27 Years - 45 Years | The University of Texas Medical Branch, Galveston | |
| B-Cell Hematologic Malignancy Vaccination Registry | NCT02298816 | Monoclonal Gamm... Multiple Myelom... Waldenstrom Mac... Lymphocytosis Lymphoma, Non-H... B-Cell Chronic ... Hematological M... | - | Aurora Health Care | ||
| Increasing Human Papillomavirus Vaccine Uptake in Low-Income, Ethnic Minority Adolescents in Los Angeles County | NCT02067507 | Human Papilloma... | Tailored educat... Staff training ... Clinic-level re... | 9 Years - 70 Years | University of California, Los Angeles | |
| Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old) | NCT05672927 | Immunization HPV Infection Human Papilloma... | 9-valent HPV va... 9-valent HPV va... | 27 Years - 45 Years | The University of Texas Medical Branch, Galveston | |
| B-Cell Hematologic Malignancy Vaccination Registry | NCT02298816 | Monoclonal Gamm... Multiple Myelom... Waldenstrom Mac... Lymphocytosis Lymphoma, Non-H... B-Cell Chronic ... Hematological M... | - | Aurora Health Care | ||
| Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype | NCT00001572 | B Cell Lymphoma Follicular Lymp... Neoplasm | Id-KLH Vaccine QS-21 (Stimulat... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Trial to Reduce Alloimmunization to Platelets (TRAP) | NCT00000589 | Blood Platelets Hematologic Dis... Immunization Leukemia, Myelo... Blood Transfusi... | platelet transf... | 15 Years - 75 Years | National Heart, Lung, and Blood Institute (NHLBI) | |
| Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype | NCT00001572 | B Cell Lymphoma Follicular Lymp... Neoplasm | Id-KLH Vaccine QS-21 (Stimulat... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs | NCT03726151 | Human Papilloma... | Parent Reminder... Multicomponent ... Combined Condit... | 11 Years - 17 Years | University of California, Los Angeles | |
| Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype | NCT00001572 | B Cell Lymphoma Follicular Lymp... Neoplasm | Id-KLH Vaccine QS-21 (Stimulat... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose | NCT03943875 | Immunization Efficacy Human Papilloma... | 9-valent HPV va... 9-valent HPV va... | 15 Years - 26 Years | The University of Texas Medical Branch, Galveston | |
| Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission | NCT01248273 | Fallopian Tubes Ovarian Cancer Peritoneal Canc... | Globo-H-GM2-sTn... | 19 Years - | Memorial Sloan Kettering Cancer Center | |
| GARDASIL 9: 3 Dose vs. 2 Dose With Delayed 3rd Dose | NCT03943875 | Immunization Efficacy Human Papilloma... | 9-valent HPV va... 9-valent HPV va... | 15 Years - 26 Years | The University of Texas Medical Branch, Galveston | |
| Increasing HPV Immunization Rates: The Rural Adolescent Vaccine Enterprise | NCT03604393 | Human Papilloma... | Practice facili... | 18 Years - 89 Years | Oregon Health and Science University | |
| PCOM2 - The Physician Communication Intervention, Version 2.0 | NCT05336240 | HPV Infection Preventive Heal... | Physician Commu... Physician Commu... | 9 Years - 17 Years | University of Colorado, Denver | |
| HPV Vaccination Study in Postpartum Women | NCT04274153 | HPV Immunization Human Papilloma... | Gardasil9 | 15 Years - 45 Years | Johns Hopkins University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
